Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.
about
Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reportsUncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.Genetic Adaptation of Achromobacter sp. during Persistence in the Lungs of Cystic Fibrosis PatientsIsolation of multiple drug-resistant enteric bacteria from feces of wild Western Lowland Gorilla (Gorilla gorilla gorilla) in GabonEpidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.A Case of Septic Shock caused by Achromobacter xylosoxidans in an Immunocompetent Female Patient after Extracorporeal Shock Wave Lithotripsy for a Ureteral Stone.Hospital Acquired Pneumonia Due to Achromobacter spp. in a Geriatric Ward in China: Clinical Characteristic, Genome Variability, Biofilm Production, Antibiotic Resistance and Integron in Isolated Strains.Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm MorphotypesState of the globe: non-fermenting gram-negative bacilli challenges and potential solutions.Nonfermenting Gram-negative Bacilli other than Pseudomonas aeruginosa and Acinetobacter Spp. Causing Respiratory Tract Infections in a Tertiary Care Center.Role of AxyZ Transcriptional Regulator in Overproduction of AxyXY-OprZ Multidrug Efflux System in Achromobacter Species Mutants Selected by Tobramycin.Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.A pan-genomic approach to understand the basis of host adaptation in Achromobacter.Impact of High Diversity of Achromobacter Populations within Cystic Fibrosis Sputum Samples on Antimicrobial Susceptibility Testing.Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients.Pseudomonas aeruginosa and Achromobacter sp. clonal selection leads to successive waves of contamination of water in dental care units.Interaction between atypical microorganisms and E. coli in catheter-associated urinary tract biofilms.Distribution of innate efflux-mediated aminoglycoside resistance among different Achromobacter species.Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe.Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens.Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.Comparative genome characterization of Achromobacter members reveals potential genetic determinants facilitating the adaptation to a pathogenic lifestyle.Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans.
P2860
Q28818541-D0F78544-6876-4E43-AEF9-44B82F98C841Q33734879-DBD9ABE5-9E77-4FF3-BBD1-91C8E50F9938Q35757359-4017ED84-7770-4722-9305-95F0EA5F2097Q35774618-35199C9C-83C9-49C0-8C21-C993539CF83FQ36061478-DC883A0F-8FD2-409B-8813-49A7629AF023Q36809131-BCCD34A8-AC37-49B7-AEB5-C080474CC72EQ36881585-98F4CF66-3126-47C5-9B55-49A8FC2A116AQ37291057-DEDE5713-D8F5-4233-9667-996AB7AE490DQ38347282-BE985243-8337-4AC4-812C-DC14DF47FC58Q38347369-E6286781-E834-4DE6-8F37-6850119CD975Q40184199-B0B4B2C1-B8D6-405E-8AEF-BD3C87BB21CAQ40226374-0544C542-8C1F-414B-A815-9B54F237733BQ40262334-6F0ADC74-591C-48C0-8F8D-9650A096D1E7Q40468493-40D3ABE6-A5B7-4DBB-A5AE-AA68F6183B24Q40507596-CB0A92F9-5654-4B8C-AA46-089617ED9588Q40618650-48E156A7-4897-443D-8D62-81CCDCBCE0FAQ41756431-79F71D00-3751-4923-A326-5221767B33FEQ41836400-E99A9A14-931D-4E39-AF5A-3DA7EB07EBC7Q42089409-185692C3-BD9A-4603-91C3-A1E7985ACACDQ42234991-58DA2A7D-CB34-4160-9CDC-67A7BF76E39EQ46286684-239B5FE4-0577-4563-93AE-3ED51B54AB69Q46884543-C240280E-A5D6-4451-877E-869CE3DBDC32Q47097212-64A1459D-93C0-4097-A09E-FF0B5E5BD133Q50923935-0C678CC0-4F3B-4815-BAC1-B016EB494B88Q55387697-2D5F71E5-B93F-408F-84BA-A3D69439512D
P2860
Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Epidemiology and resistance of ...... , Burgundy: first French data.
@ast
Epidemiology and resistance of ...... , Burgundy: first French data.
@en
type
label
Epidemiology and resistance of ...... , Burgundy: first French data.
@ast
Epidemiology and resistance of ...... , Burgundy: first French data.
@en
prefLabel
Epidemiology and resistance of ...... , Burgundy: first French data.
@ast
Epidemiology and resistance of ...... , Burgundy: first French data.
@en
P2093
P1476
Epidemiology and resistance of ...... , Burgundy: first French data.
@en
P2093
Annlyse Fanton
Catherine Neuwirth
Eliane Siebor
Julien Bador
Lucie Amoureux
Nathalie Taillefumier
P304
P356
10.1016/J.JCF.2012.08.005
P577
2012-09-01T00:00:00Z